完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Su, Chia-Wei | en_US |
dc.contributor.author | Fan, Ting-Hsi | en_US |
dc.contributor.author | Li, Wei-Ming | en_US |
dc.contributor.author | Chen, San-Yuan | en_US |
dc.date.accessioned | 2014-12-08T15:36:51Z | - |
dc.date.available | 2014-12-08T15:36:51Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.issn | 1359-7345 | en_US |
dc.identifier.uri | http://hdl.handle.net/11536/25258 | - |
dc.identifier.uri | http://dx.doi.org/10.1039/c4cc02717e | en_US |
dc.description.abstract | A newly-designed drug carrier composed of an internal droplet core and a thickness-controllable shell was successfully developed. By co-delivering paclitaxel, doxorubicin and quantum dots simultaneously, this combinational drug delivery system could achieve in vitro fluorescence imaging, chemotherapeutic and oxidation therapy. | en_US |
dc.language.iso | en_US | en_US |
dc.title | Synergistic combination therapy using a lipid shell-droplet core nanosphere with tunable thickness | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1039/c4cc02717e | en_US |
dc.identifier.journal | CHEMICAL COMMUNICATIONS | en_US |
dc.citation.volume | 50 | en_US |
dc.citation.issue | 77 | en_US |
dc.citation.spage | 11291 | en_US |
dc.citation.epage | 11294 | en_US |
dc.contributor.department | 交大名義發表 | zh_TW |
dc.contributor.department | 材料科學與工程學系 | zh_TW |
dc.contributor.department | National Chiao Tung University | en_US |
dc.contributor.department | Department of Materials Science and Engineering | en_US |
dc.identifier.wosnumber | WOS:000341359000003 | - |
dc.citation.woscount | 0 | - |
顯示於類別: | 期刊論文 |